TEVA - Teva Pharmaceutical Industries Limited

NYSE - NYSE Delayed Price. Currency in USD
21.09
-0.14 (-0.66%)
At close: 4:01PM EDT

21.26 +0.17 (0.81%)
Pre-Market: 4:03AM EDT

Stock chart is not supported by your current browser
Previous Close21.23
Open21.49
Bid0.00 x 900
Ask22.90 x 1000
Day's Range20.94 - 21.49
52 Week Range10.85 - 33.82
Volume8,690,912
Avg. Volume11,274,553
Market Cap21.474B
Beta1.01
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend Date2017-11-27
1y Target EstN/A
Trade prices are not sourced from all markets
  • Benzinga2 days ago

    Cantor Fitzgerald: 18 Drug Companies With Catalysts Worth Watching

    The biotech analysts at Cantor Fitzgerald have a packed calendar: here are some of the dates they’re tracking and why they’re important. Mallinckrodt PLC (NYSE: MNK ) is expected to release Phase 4 interim ...

  • Pharma Stock Roundup: Zoetis to Buy Abaxis, NVS Gets FDA Nod for Migraine Drug
    Zacks4 days ago

    Pharma Stock Roundup: Zoetis to Buy Abaxis, NVS Gets FDA Nod for Migraine Drug

    Novartis' (NVS) CGRP antibody, Aimovig gains FDA approval for prevention of migraine. Zoetis (ZTS) and Lilly (LLY) announce deals to buy smaller companies.

  • Amgen's Migraine Drug Aimovig Gets FDA Approval, Shares Up
    Zacks4 days ago

    Amgen's Migraine Drug Aimovig Gets FDA Approval, Shares Up

    Amgen's (AMGN) preventive treatment for migraine, Aimovig, gets approval in the United States.

  • Buffett Gets Even Greedier With Teva Pharmaceuticals. Time to Buy?
    Motley Fool4 days ago

    Buffett Gets Even Greedier With Teva Pharmaceuticals. Time to Buy?

    America's favorite investor doubled down on a bet that this trainwreck isn't as bad as it looks. Should you follow?

  • Investopedia4 days ago

    13F: Buffett Increased Apple, Monsanto & Teva

    Warren Buffett, the billionaire investor and famed Oracle of Omaha, saw the stock portfolio of his Berkshire Hathaway decline by about $2 billion in Q1, according to recent filings with the SEC. The top five positions in Buffett's portfolio represent a whopping two thirds of the entire 13F investment package for the company. As of the end of March, AAPL was the largest portfolio stake for Berkshire Hathaway, accounting for more than 21% of the company's investments, according to its 13F filing.

  • Company News For May 17, 2018
    Zacks5 days ago

    Company News For May 17, 2018

    Companies In The News are: FOXA,IQV,ABAX,ZTS,TEVA,BRK.B

  • The Top Stocks Warren Buffett Is Buying Now
    Motley Fool5 days ago

    The Top Stocks Warren Buffett Is Buying Now

    It might be smart to add these Berkshire Hathaway buys to your portfolio, too.

  • Teva’s Fiscal Guidance: Confidence in Its Growth
    Market Realist5 days ago

    Teva’s Fiscal Guidance: Confidence in Its Growth

    Teva Pharmaceutical (TEVA) provided an increased guidance for this fiscal year during its first-quarter earnings release on May 3. The company has made an upward revision to its guidance for this fiscal year. Teva reported better-than-expected results in the fiscal first quarter.

  • Benzinga6 days ago

    Warren Buffett Pushing More Cash To Equities; 'Big 5' Stocks Still At The Top

    Warren Buffett’s Berkshire Hathaway Inc. (NYSE: BRK-A ) (NYSE: BRK-B ) filed its 13F for the first quarter on Tuesday, revealing what changes it made to its portfolio during the period. The company’s equity ...

  • Reuters6 days ago

    Berkshire doubles Teva stake, adds to Apple, ends a newspaper bet

    ((Corrects ninth paragraph in May 15 article because of data error, and to show that Berkshire Hathaway is Apple's third-largest shareholder, trailing Vanguard Group and BlackRock, not its second-large) ...

  • Teva’s Debt Reduction Plans Progress, Targets Are on Track
    Market Realist6 days ago

    Teva’s Debt Reduction Plans Progress, Targets Are on Track

    Teva Pharmaceutical (TEVA) has been working towards paying down the high level of debt on its balance sheet. Teva obtained the debt in 2016 to fund the acquisition of Allergan’s (AGN) generic business. At the end of fiscal 2017, Teva had a net debt of $31.5 billion on its balance sheet.

  • InvestorPlace6 days ago

    Teva Pharmaceutical Industries Ltd, Once a Falling Machete, Is Spiking — Chase It

    Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) stock has been decimated over the years. This morning the stock is rallying on the news that the famed investor Warren Buffett doubled his stake in Teva stock. Wall Street loves to chase Buffett’s investments.

  • Reuters6 days ago

    Berkshire doubles Teva stake, adds to Apple, ends a newspaper bet

    Warren Buffett's Berkshire Hathaway Inc on Tuesday said it has more than doubled its investment in generic drugmaker Teva Pharmaceutical Industries Ltd , and confirmed it has become Apple Inc's second-largest ...

  • Why Did Teva Stock Increase on May 14?
    Market Realist6 days ago

    Why Did Teva Stock Increase on May 14?

    On May 14, Teva (TEVA) stock increased ~5.5% on the news of the expected delay in the FDA approval for rival Perrigo’s (PRGO) generic version of Teva’s asthma inhaler ProAir. On May 14, Teva stock closed at a trading price of $20.38 per share.

  • Analysts’ Recommendations for AstraZeneca as of May 15
    Market Realist6 days ago

    Analysts’ Recommendations for AstraZeneca as of May 15

    Analysts expect AstraZeneca (AZN) to report EPS (earnings per share) of $0.60 on revenue of $5.3 billion in the first quarter, a 2.3% fall compared to its revenue of $5.4 billion during the first quarter of 2017. AstraZeneca’s stock price has risen nearly 7.1% over the last 12 months and ~4.9% year-to-date.

  • Eli Lilly's Cluster Headache Candidate Succeeds in Phase III
    Zacks6 days ago

    Eli Lilly's Cluster Headache Candidate Succeeds in Phase III

    Eli Lilly's (LLY) galcanezumab meets the primary endpoint in a late-stage study evaluating it for the prevention of episodic cluster headache.

  • Stocks Inch Up, Dow Jones Lags; Boot Barn Spikes Out Of Buy Range
    Investor's Business Daily6 days ago

    Stocks Inch Up, Dow Jones Lags; Boot Barn Spikes Out Of Buy Range

    The Dow Jones industrials lagged Wednesday's early action as the market defended narrow gains. Teva, Macy's, Boot Barn and China's Tencent set up early leads.

  • TheStreet.com6 days ago

    Teva Shares Jump After Warren Buffett Doubles Stake in Drugmaker

    Warren Buffett's seal of approval was helping restructuring drugmaker Teva Pharmaceutical Industries Ltd. Teva's ADRs jumped 4.1% to $21.13 in early trading on Wednesday, May 16, after Buffett's Berkshire Hathaway Inc. Berkshire Hathaway increased its stake in Teva to 40.5 million shares, or about $692.8 million, as of the end of March, up from 18.9 million shares worth a total of $357.7 million as of the end of 2017.

  • Teva Shares Rose on May 15, Berkshire Increased Its Stake
    Market Realist6 days ago

    Teva Shares Rose on May 15, Berkshire Increased Its Stake

    On May 15 after the market closed, Berkshire Hathaway (BRKB) published its holdings at the end of the first quarter as of March 31. According to the company’s SEC filings, it holds 40.5 million Teva Pharmaceutical (TEVA) shares as of March 31—compared to 19 million shares added during the fourth quarter of 2017, according to Berkshire’s filings as of December 31, 2017. At the time, Teva stock rose more than 10% following the news.

  • Teva Stock Up 5% as Buffett's Berkshire Raises Stake in Q1
    Zacks6 days ago

    Teva Stock Up 5% as Buffett's Berkshire Raises Stake in Q1

    Teva's (TEVA) shares gain 5% after Warren Buffett's Berkshire Hathaway reveals an increased stake in the company.

  • How Valeant Pharmaceuticals’ Branded Rx Segment Performed in 1Q18
    Market Realist6 days ago

    How Valeant Pharmaceuticals’ Branded Rx Segment Performed in 1Q18

    In 1Q18, Valeant Pharmaceuticals (VRX) Branded Rx segment generated revenues of $593.0 million, compared to $629.0 million in 1Q17. This reflected ~6.0% growth on a year-over-year (or YoY) basis and an ~1.0% decline quarter-over-quarter.

  • Investopedia6 days ago

    Buffett Buys More Apple and Teva Shares, Dumps IBM

    Berkshire Hathaway doubles its stake in Teva, becomes Apple’s second-largest shareholder and exits its positions in IBM and Graham.

  • Here's What Warren Buffett Is Buying and Selling
    Motley Fool6 days ago

    Here's What Warren Buffett Is Buying and Selling

    We didn’t get many big surprises, but the Oracle of Omaha did make some notable stock transactions in the first quarter.

  • Associated Press6 days ago

    Buffett's company doubles investment in drugmaker Teva

    Investor Warren Buffett's company more than doubled its stake in Israeli drugmaker Teva Pharmaceuticals in the first quarter. Berkshire Hathaway Inc. filed an update on its U.S. stock portfolio with the Securities and Exchange Commission on Tuesday. Berkshire said it held 40.5 million Teva shares at the end of March.

  • CNBC6 days ago

    After-hours buzz: TEVA, MON, MU & more

    See which stocks are posting big moves after the bell.